EU weighs plan to incentivize drugmakers to fight superbugs
A Netflix-style subscription model following the UK’s example could incentivize antibiotic making to curb to the increasingly gloomy prospects of drug-resistant infections.
.jpg)
By Lyubov Pronina, Naomi Kresge, & Lisa Pham, bloomberg
The European Union is considering a plan to guarantee revenues to drugmakers to incentivize them to develop new antibiotics, potentially following the UK toward a Netflix-style subscription model after earlier proposals for a voucher program drew criticism.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
